Align Technology, Inc. (NASDAQ:ALGN) is a global medical device company known for its Invisalign clear aligners and iTero intraoral scanners. Operating in the dental and orthodontics industry, Align competes with firms like Dentsply Sirona and 3M. Its innovative products have positioned it as a market leader, driving growth and investor interest.
On October 30, 2025, Jonathan Block from Stifel Nicolaus set a price target of $200 for Align Technology. At the time, the stock was priced at $141.55, suggesting a potential increase of about 41.29%. This optimistic outlook reflects confidence in Align's strategic direction and financial performance, as discussed in their recent Q3 2025 earnings call.
During the Q3 2025 earnings call, key figures like CEO Joseph Hogan and CFO John Morici provided insights into Align's financial health. The stock price at the time of the call was $140.08, showing a 6.19% increase or $8.17. The day's trading saw fluctuations between $139.39 and $150.78, indicating active investor interest.
Align Technology's market capitalization stands at approximately $10.15 billion, highlighting its significant presence in the industry. The stock's 52-week range shows a high of $246.19 and a low of $122, reflecting its volatility and potential for growth. The trading volume on the NASDAQ exchange was 1,597,174 shares, underscoring strong market activity.
The earnings call featured analysts from various research divisions, including Jonathan Block, who reiterated a buy rating. This aligns with the positive sentiment surrounding Align's future prospects, as the company continues to innovate and expand its market share in the dental and orthodontics sector.
